Genomics

Dataset Information

The PPAR agonist Rosiglitazone induces paracrine signaling in melanoma cells that activate stromal cells and enhances tumor growth.


ABSTRACT: The PPAR agonist Rosiglitazone induces paracrine signaling in melanoma cells that activate stromal cells and enhances tumor growth.

PROVIDER: PRJNA474184 | ENA |

REPOSITORIES: ENA